Susan Strobl

494 total citations
13 papers, 384 citations indexed

About

Susan Strobl is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Susan Strobl has authored 13 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Susan Strobl's work include Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Susan Strobl is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Susan Strobl collaborates with scholars based in United States, Germany and Japan. Susan Strobl's co-authors include Anatoli Malyguine, Kimberly Shafer-Weaver, Michael Baseler, Thomas J. Sayers, Michael R. Shurin, Eric Derby, Kimberly Dunham, Liubov Zaritskaya, Edward L. Nelson and William C. Kopp and has published in prestigious journals such as Cancer Research, The FASEB Journal and Journal of Immunological Methods.

In The Last Decade

Susan Strobl

13 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Strobl United States 11 294 132 89 48 34 13 384
Adam Giermasz United States 7 554 1.9× 143 1.1× 98 1.1× 33 0.7× 26 0.8× 8 611
Theres Oakes United Kingdom 9 326 1.1× 117 0.9× 140 1.6× 39 0.8× 32 0.9× 12 435
Jingjing She United States 8 408 1.4× 120 0.9× 81 0.9× 64 1.3× 29 0.9× 13 480
E Braakman Netherlands 7 456 1.6× 144 1.1× 115 1.3× 53 1.1× 27 0.8× 15 597
Susanne Oberle Switzerland 10 506 1.7× 252 1.9× 126 1.4× 55 1.1× 31 0.9× 12 630
Laura Santodonato Italy 12 292 1.0× 183 1.4× 88 1.0× 36 0.8× 91 2.7× 15 394
Saho Maruyama Japan 11 330 1.1× 58 0.4× 115 1.3× 46 1.0× 32 0.9× 18 454
Karoline W. Schjetne Norway 11 310 1.1× 117 0.9× 107 1.2× 63 1.3× 28 0.8× 28 401
Carmen Stecher Austria 5 420 1.4× 222 1.7× 75 0.8× 45 0.9× 42 1.2× 11 532
Dora Pinto Italy 10 264 0.9× 57 0.4× 93 1.0× 50 1.0× 18 0.5× 11 380

Countries citing papers authored by Susan Strobl

Since Specialization
Citations

This map shows the geographic impact of Susan Strobl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Strobl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Strobl more than expected).

Fields of papers citing papers by Susan Strobl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Strobl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Strobl. The network helps show where Susan Strobl may publish in the future.

Co-authorship network of co-authors of Susan Strobl

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Strobl. A scholar is included among the top collaborators of Susan Strobl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Strobl. Susan Strobl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lo, Chia-Yun, Susan Strobl, Kimberly Dunham, et al.. (2017). Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic. Open Forum Infectious Diseases. 4(2). ofx023–ofx023. 6 indexed citations
2.
Malyguine, Anatoli, Susan Strobl, Kimberly Dunham, Michael R. Shurin, & Thomas J. Sayers. (2012). ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials. Cells. 1(2). 111–126. 46 indexed citations
3.
Malyguine, Anatoli, Susan Strobl, & Michael R. Shurin. (2011). Immunological monitoring of the tumor immunoenvironment for clinical trials. Cancer Immunology Immunotherapy. 61(2). 239–247. 21 indexed citations
4.
Zaritskaya, Liubov, Kimberly Shafer-Weaver, Melissa K. Gregory, et al.. (2009). Application of a Flow Cytometric Cytotoxicity Assay for Monitoring Cancer Vaccine Trials. Journal of Immunotherapy. 32(2). 186–194. 15 indexed citations
5.
Malyguine, Anatoli, Susan Strobl, Liubov Zaritskaya, Michael Baseler, & Kimberly Shafer-Weaver. (2007). New Approaches for Monitoring CTL Activity in Clinical Trials. Advances in experimental medicine and biology. 601. 273–284. 26 indexed citations
6.
Shafer-Weaver, Kimberly, Steven A. Rosenberg, Susan Strobl, et al.. (2006). Application of the Granzyme B ELISPOT Assay for Monitoring Cancer Vaccine Trials. Journal of Immunotherapy. 29(3). 328–335. 27 indexed citations
7.
Garcı́a-Piñeres, Alfonso, Allan Hildesheim, Marcus Williams, et al.. (2006). DNAse treatment following thawing of Cryopreserved PBMC is a procedure suitable for lymphocyte functional studies. Journal of Immunological Methods. 313(1-2). 209–213. 17 indexed citations
8.
Shafer-Weaver, Kimberly, et al.. (2005). A Novel Flow Cytometric Assay for Evaluating Cell-Mediated Cytotoxicity. Journal of Immunotherapy. 28(4). 396–402. 41 indexed citations
9.
Strobl, Susan, Sattva S. Neelapu, Kimberly Shafer-Weaver, et al.. (2004). A modified IFN-γ ELISPOT assay to detect specific responses to human primary tumor cells. Cancer Research. 64. 283–283. 1 indexed citations
10.
Malyguine, Anatoli, Susan Strobl, Kimberly Shafer-Weaver, et al.. (2004). A modified human ELISPOT assay to detect specific responses to primary tumor cell targets. Journal of Translational Medicine. 2(1). 9–9. 30 indexed citations
11.
Shafer-Weaver, Kimberly, Thomas J. Sayers, Douglas B. Kuhns, et al.. (2004). Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay.. Journal of Translational Medicine. 2(1). 31–31. 25 indexed citations
12.
Shafer-Weaver, Kimberly, Thomas J. Sayers, Susan Strobl, et al.. (2003). The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity. Journal of Translational Medicine. 1(1). 14–14. 96 indexed citations
13.
Nelson, Edward L., Susan Strobl, Jeff Subleski, et al.. (1999). Cycling of human dendritic cell effector phenotypes in response to TNF‐α: modification of the current ‘maturation’ paradigm and implications for in vivo immunoregulation. The FASEB Journal. 13(14). 2021–2030. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Giermasz Breakdown of academic impact, for papers by Theres Oakes Breakdown of academic impact, for papers by Jingjing She Breakdown of academic impact, for papers by E Braakman Breakdown of academic impact, for papers by Susanne Oberle Breakdown of academic impact, for papers by Laura Santodonato Breakdown of academic impact, for papers by Saho Maruyama Breakdown of academic impact, for papers by Karoline W. Schjetne Breakdown of academic impact, for papers by Carmen Stecher Breakdown of academic impact, for papers by Dora Pinto
Rankless by CCL
2026